Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 868315Generated: November 1, 2026

(S)-2-Hydroxy-2-(6-(hydroxymethyl)-5-oxo-2,3-dihydro-5H-spiro[indolizine-1,2'-[1,3]dioxolan]-7-yl)-N-((S)-1-phenylethyl)butanamide → (4S)-4-Ethyl-7,8-dihydro-4-hydroxy-1H-pyrano(3,4-f)indolizine-3,6,10(4H)-trione

https://huagongshe.com/reaction/868315

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(S)-2-Hydroxy-2-(6-(hydroxymethyl)-5-oxo-2,3-dihydro-5H-spiro[indolizine-1,2'-[1,3]dioxolan]-7-yl)-N-((S)-1-phenylethyl)butanamideHCID 11122829—
SolventTrifluoroacetic acidHCID 6422—
Product(4S)-4-Ethyl-7,8-dihydro-4-hydroxy-1H-pyrano(3,4-f)indolizine-3,6,10(4H)-trioneHCID 1022090092.2%

Reaction Steps

Three hundred milligrams of the compound (VII) obtained in the above procedure (1) were dissolved in 80% trifluoroacetic acid solution and the resulting mixture was stirred at room temperature for 2 hours under a nitrogen gas stream. The reaction mixture was concentrated to dryness and the residue was purified by column chromatography on silica gel (10 g). A colorless oily substance was obtained from a 98:2 eluate of chloroform and methanol. The oily substance was crystallized from a mixed solvent of ethanol and petroleum ether to obtain 170 mg of the title compound as colorless needle-like crystals.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04778891
Source datasetuspto-grants-1988_10
ORD IDord-af3463de5c3049afa97c6e8c001aff25
Source noteuspto-grants-1988_10